Detalles de la búsqueda
1.
Silmitasertib plus gemcitabine and cisplatin first-line therapy in locally advanced/metastatic cholangiocarcinoma: A Phase 1b/2 study.
Hepatology
; 77(3): 760-773, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36152015
2.
A multicenter phase Ia study of AbGn-107, a novel antibody-drug conjugate, in patients with advanced gastrointestinal cancer.
Invest New Drugs
; 42(2): 221-228, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38441850
3.
Impact of previous S-1 treatment on efficacy of liposomal irinotecan plus 5-fluorouracil and leucovorin in patients with metastatic pancreatic cancer.
Pancreatology
; 2024 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38565467
4.
Discovery of the tryptanthrin-derived indoloquinazoline as an anti-breast cancer agent via ERK/JNK activation.
Environ Toxicol
; 39(6): 3710-3720, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38511855
5.
Comparison of therapeutic outcomes in esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy: A prospective observational cohort study.
J Formos Med Assoc
; 123(1): 106-115, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37385933
6.
Adjuvant chemotherapy for stage II and III gastric adenocarcinoma: A retrospective analysis with long-term follow-up.
J Formos Med Assoc
; 2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38719675
7.
EZH2-mediated epigenetic silencing of tumor-suppressive let-7c/miR-99a cluster by hepatitis B virus X antigen enhances hepatocellular carcinoma progression and metastasis.
Cancer Cell Int
; 23(1): 199, 2023 Sep 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37689710
8.
Extract of Ficus septica modulates apoptosis and migration in human oral squamous cell carcinoma cells.
Environ Toxicol
; 38(3): 666-675, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36436203
9.
Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 23(2): 234-247, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35030335
10.
Pembrolizumab versus paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer (KEYNOTE-063): A randomized, open-label, phase 3 trial in Asian patients.
Cancer
; 128(5): 995-1003, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34878659
11.
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study.
Gastric Cancer
; 25(1): 207-217, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34480657
12.
Trajectories of symptom severity predicts quality of life change in newly diagnosis lymphoma survivors: An initial study.
Eur J Cancer Care (Engl)
; 31(6): e13741, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36254839
13.
Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study.
Lancet Oncol
; 22(10): 1468-1482, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34592180
14.
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab.
Gastric Cancer
; 24(4): 946-958, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33743112
15.
TRIM21 Polymorphisms are associated with Susceptibility and Clinical Status of Oral Squamous Cell Carcinoma patients.
Int J Med Sci
; 18(13): 2997-3003, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34220328
16.
Antitumor Effects of a Sesquiterpene Derivative from Marine Sponge in Human Breast Cancer Cells.
Mar Drugs
; 19(5)2021 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33925873
17.
A macrolide from Streptomyces sp. modulates apoptosis and autophagy through Mcl-1 downregulation in human breast cancer cells.
Environ Toxicol
; 36(7): 1316-1325, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33713530
18.
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer.
Gastric Cancer
; 23(1): 143-153, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31087200
19.
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data.
Gastric Cancer
; 23(3): 510-519, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31863227
20.
Antitumor Activity of the Cardiac Glycoside αlDiginoside by Modulating Mcl-1 in Human Oral Squamous Cell Carcinoma Cells.
Int J Mol Sci
; 21(21)2020 Oct 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33114727